GlassScriptPhysician profile
Diamond M Goodwin
NPI 1073044624
$4,037.16
in general payments reported to CMS, 2019-2025
16 companies · $516 in 2025
The $516 reported for 2025 was more than what 75% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $35.17 · 2023: $391 · 2024: $3,095 · 2025: $516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,250 · Food and Beverage: $1,558 · Travel and Lodging: $185 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,250.00 |
| Food and Beverage | $1,557.82 |
| Travel and Lodging | $185.43 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,861.58 | 2024 | |
| Sumitomo Pharma America, INC. | $172.63 | 2023-2025 | Myfembree |
| Sage Therapeutics, LLC | $126.21 | 2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $123.97 | 2023 | |
| Ethicon US, LLC | $123.87 | 2023 | Stratafix |
| Dompe US, INC. | $121.57 | 2023 | Oxervate |
| Meditrina | $118.35 | 2024 | |
| Astellas Pharma US INC | $115.39 | 2024 | Veozah |
| Exeltis, USA INC. | $85.11 | 2025 | Slynd |
| Coopersurgical, INC. | $50.67 | 2025 | |
| Myovant Sciences INC. | $35.17 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $34.99 | 2025 | |
| Abbvie INC. | $21.98 | 2025 | |
| Novo Nordisk INC | $16.07 | 2025 | Wegovy |
| Evofem Biosciences, INC. | $15.79 | 2025 | Phexxi, Solosec, Phexx |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $13.81 | 2025 | Femlyv, Intrarosa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diamond Goodwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.